Showing 1,801 - 1,820 results of 21,342 for search '(( significant ((role decrease) OR (group decreased)) ) OR ( significant decrease decrease ))', query time: 0.61s Refine Results
  1. 1801
  2. 1802
  3. 1803
  4. 1804
  5. 1805

    Study Data. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
  6. 1806

    Study outcomes. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
  7. 1807

    Patient characteristics. by Jonathan S. Jahr (2709088)

    Published 2025
    “…The average heart rate (HR) slowing (3.2 bpm ± 3.9 in the control group, 3.7 bpm ± 3.8 in the dexamethasone group), and maximal HR slowing (5.0 bpm ± 3.9 in the control group, 5.0 bpm ± 3.8 in the dexamethasone group) over the five minutes following sugammadex administration were not significant between groups (average HR slowing p = 0.553, maximal HR slowing p = 0.988). …”
  8. 1808
  9. 1809
  10. 1810
  11. 1811
  12. 1812
  13. 1813

    Raw data. by Saeedeh Abbasi (9423189)

    Published 2025
    Subjects:
  14. 1814

    Data. by Saeedeh Abbasi (9423189)

    Published 2025
    Subjects:
  15. 1815
  16. 1816
  17. 1817
  18. 1818
  19. 1819
  20. 1820